Page last updated: 2024-09-04

daunosamine and 2-pyrrolino-dox

daunosamine has been researched along with 2-pyrrolino-dox in 1 studies

Compound Research Comparison

Studies (daunosamine)	Trials (daunosamine)	Recent Studies (post-2010) (daunosamine)	Studies (2-pyrrolino-dox)	Trials (2-pyrrolino-dox)	Recent Studies (post-2010) (2-pyrrolino-dox)
32	0	5	28	0	2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brabec, V; Kasparkova, J; Liskova, B; Malina, J; Novakova, O; Stepankova, J; Studenovsky, M; Ulbrich, K	1

Other Studies

1 other study(ies) available for daunosamine and 2-pyrrolino-dox

Article	Year
DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin. Biochemical pharmacology, 2011, Aug-01, Volume: 82, Issue:3 Topics: Animals; Antineoplastic Agents; Cell-Free System; DNA; DNA Adducts; DNA Topoisomerases, Type II; Doxorubicin; Gene Expression Regulation, Neoplastic; Hexosamines; Humans; Mice; Molecular Structure; Pyrroles; Topoisomerase II Inhibitors; Transcription, Genetic	2011

Article

Year

DNA interactions of 2-pyrrolinodoxorubicin, a distinctively more potent daunosamine-modified analogue of doxorubicin.

Biochemical pharmacology, 2011, Aug-01, Volume: 82, Issue:3

Topics: Animals; Antineoplastic Agents; Cell-Free System; DNA; DNA Adducts; DNA Topoisomerases, Type II; Doxorubicin; Gene Expression Regulation, Neoplastic; Hexosamines; Humans; Mice; Molecular Structure; Pyrroles; Topoisomerase II Inhibitors; Transcription, Genetic

2011